"Living Cell Therapy Shows Dramatic Progress Against Glioblastoma Tumors"

A phase 1 clinical trial at the Mass General Cancer Center has shown promising early results in treating glioblastoma, a lethal brain cancer, with a novel CAR-T cell therapy. The treatment, which involves specially engineered T-cells injected directly into the fluid around the brain, has demonstrated dramatic and rapid tumor reduction in early trials. While more research is needed, the initial findings provide hope for improved treatment options for this aggressive form of cancer.